Clinical Study About the Effects of Scuba Diving on Post Traumatic Stress Disorder (PTSD)

NCT ID: NCT04343924

Last Updated: 2024-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-07

Study Completion Date

2023-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-traumatic stress disorder (PTSD) is a set of symptoms that can be developed as a result of exposure to a traumatic event or events that can range in prevalence from 25% to 75%. While therapeutic management combines psychotherapy, drug therapy and social support, some PTSD remain resistant after early and appropriate initial treatment. In terms of physiopathology, several studies have shown that parasympathetic activity is significantly decreased in patients with PTSD. In scuba diving, the cardio-vascular stresses associated with submersion of the subject and the lungs due to breathing in a regulator are at the origin of a reflex activation of the parasympathetic nervous system. The objective is to study the effects of the scuba diving activities-induced autonomic parasympathetic nervous system activation on the symptomatic progression of patients with PTSD.

The study population will consist of patients monitored and treated for PTSD following the attacks of 14/07/2016 in Nice (France).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A group will be composed of patients (n=12) who will complete a Scuba Diving Discovery Course (GP+ Diving Group). This course, lasting 2 weeks, will consist of a daily dive, 5 days per week, for a total of 10 dives. These will be supervised by a graduate instructor according to the rules of supervision defined by the sport code. The dives will be conducted in open air, at a maximum depth of 6 meters for a maximum duration of 20 minutes.

A matched group (gender, age, height, weight and BMI) will be composed of patients (n=12) who will not complete the Scuba Diving Discovery Course (GP- Virtual reality group). The subjects of this group will follow virtual reality sessions recreating the environment in which the scuba divers of the GP+ group operate. A control group (GT) will be composed of patients (n=12) who are monitored and treated for PTSD and who will not attend the dive discovery course or virtual reality sessions.

* The main evaluation criterion will be the NON-INVASIVE determination of salivary alpha amylase.
* Secondary evaluation criteria will be heart rate variation, CGI, HAD and BECK Anxiety, EGF, PCL-S and IES questionary.

The main objective is to study the effects of immersion and pressure relief ventilation on the activation of the autonomic parasympathetic nervous system.

Secondary objectives are to assess the symptomatic impact of parasympathetic autonomic nervous system activation on overall improvement, anxiety and depressive symptoms, functioning, and the 3 subtypes of PTSD symptoms as vegetative neuro hyperactivity, invasive syndrome and avoiding

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diving Group

The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.

Group Type EXPERIMENTAL

Scuba diving activities

Intervention Type OTHER

The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.

Virtual reality Group

The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates.

Group Type ACTIVE_COMPARATOR

Virtual reality activities

Intervention Type OTHER

The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates

Control Group

The subjects of this group will be monitored and treated for PTSD and will not attend the dive discovery course or virtual reality sessions.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Scuba diving activities

The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.

Intervention Type OTHER

Virtual reality activities

The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients
* Patients who understand and read French
* Patients who have signed the informed consent form
* Patients who have never practiced scuba diving
* Patients medically fit for scuba diving
* Patients with the DSM-5 criteria for Post-traumatic Stress Disorder
* PCL-S score strictly greater than 44
* CGI greater than or equal to 4
* Chronicity (duration greater than 3 months)

Exclusion Criteria

* Women of reproductive age without contraception
* Pregnant or nursing women
* Patients under guardianship or curatorship and detainees of justice
* Patients who previously practised scuba diving or hold a diving certificate
* Patients whose medical condition medically contraindicated the practice of scuba diving,
* Patients having a water phobia, bipolar or psychotic disorder
* Patients with a severe and proven suicidal risk (MINI-S and medical examination)
* Patients treated for less than 2 months with antidepressants;
* Patients treated for less than 2 months with specific psychotherapy (Cognitive and Behavioural Therapy, EMDR)
* Patients with response to treatment (50% decrease in symptoms)
* Contraindications to the practice of virtual reality.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nice

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carl WILLEM

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Nice

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Nice

Nice, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19-PP-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

tDCS Plus Virtual Reality for PTSD
NCT03372460 COMPLETED NA
Prolonged Exposure and Oxytocin
NCT03238924 COMPLETED PHASE2
Non Invasive Brain Stimulation for PTSD
NCT02442843 COMPLETED EARLY_PHASE1